rs2229917

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_004408.4(DNM1):​c.312G>A​(p.Glu104Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.072 in 1,613,176 control chromosomes in the GnomAD database, including 5,489 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1342 hom., cov: 31)
Exomes 𝑓: 0.068 ( 4147 hom. )

Consequence

DNM1
NM_004408.4 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.62

Publications

9 publications found
Variant links:
Genes affected
DNM1 (HGNC:2972): (dynamin 1) This gene encodes a member of the dynamin subfamily of GTP-binding proteins. The encoded protein possesses unique mechanochemical properties used to tubulate and sever membranes, and is involved in clathrin-mediated endocytosis and other vesicular trafficking processes. Actin and other cytoskeletal proteins act as binding partners for the encoded protein, which can also self-assemble leading to stimulation of GTPase activity. More than sixty highly conserved copies of the 3' region of this gene are found elsewhere in the genome, particularly on chromosomes Y and 15. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
DNM1 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 31A
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • developmental and epileptic encephalopathy, 31B
    Inheritance: AR, AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004408.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.2).
BP6
Variant 9-128218658-G-A is Benign according to our data. Variant chr9-128218658-G-A is described in ClinVar as Benign. ClinVar VariationId is 380778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.62 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.22 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004408.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNM1
NM_004408.4
MANE Select
c.312G>Ap.Glu104Glu
synonymous
Exon 3 of 22NP_004399.2Q05193-1
DNM1
NM_001374269.1
c.312G>Ap.Glu104Glu
synonymous
Exon 3 of 22NP_001361198.1A0A994J7J4
DNM1
NM_001288739.2
c.312G>Ap.Glu104Glu
synonymous
Exon 3 of 22NP_001275668.1Q05193-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNM1
ENST00000372923.8
TSL:1 MANE Select
c.312G>Ap.Glu104Glu
synonymous
Exon 3 of 22ENSP00000362014.4Q05193-1
DNM1
ENST00000486160.3
TSL:1
c.312G>Ap.Glu104Glu
synonymous
Exon 3 of 22ENSP00000420045.1Q05193-2
DNM1
ENST00000634267.2
TSL:5
c.312G>Ap.Glu104Glu
synonymous
Exon 3 of 22ENSP00000489096.1A0A0U1RQP1

Frequencies

GnomAD3 genomes
AF:
0.109
AC:
16569
AN:
151940
Hom.:
1335
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.223
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.0745
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.00309
Gnomad SAS
AF:
0.0702
Gnomad FIN
AF:
0.0394
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.0693
Gnomad OTH
AF:
0.109
GnomAD2 exomes
AF:
0.0717
AC:
17944
AN:
250324
AF XY:
0.0713
show subpopulations
Gnomad AFR exome
AF:
0.230
Gnomad AMR exome
AF:
0.0457
Gnomad ASJ exome
AF:
0.118
Gnomad EAS exome
AF:
0.00327
Gnomad FIN exome
AF:
0.0385
Gnomad NFE exome
AF:
0.0706
Gnomad OTH exome
AF:
0.0771
GnomAD4 exome
AF:
0.0681
AC:
99515
AN:
1461118
Hom.:
4147
Cov.:
33
AF XY:
0.0686
AC XY:
49865
AN XY:
726746
show subpopulations
African (AFR)
AF:
0.230
AC:
7707
AN:
33458
American (AMR)
AF:
0.0484
AC:
2160
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
3050
AN:
26122
East Asian (EAS)
AF:
0.00189
AC:
75
AN:
39690
South Asian (SAS)
AF:
0.0700
AC:
6034
AN:
86198
European-Finnish (FIN)
AF:
0.0406
AC:
2162
AN:
53304
Middle Eastern (MID)
AF:
0.135
AC:
778
AN:
5766
European-Non Finnish (NFE)
AF:
0.0655
AC:
72825
AN:
1111544
Other (OTH)
AF:
0.0783
AC:
4724
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5529
11058
16586
22115
27644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2734
5468
8202
10936
13670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.109
AC:
16605
AN:
152058
Hom.:
1342
Cov.:
31
AF XY:
0.105
AC XY:
7827
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.224
AC:
9257
AN:
41398
American (AMR)
AF:
0.0743
AC:
1137
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
407
AN:
3468
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5172
South Asian (SAS)
AF:
0.0701
AC:
338
AN:
4824
European-Finnish (FIN)
AF:
0.0394
AC:
418
AN:
10602
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.0693
AC:
4712
AN:
67978
Other (OTH)
AF:
0.107
AC:
227
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
737
1475
2212
2950
3687
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0808
Hom.:
536
Bravo
AF:
0.115
Asia WGS
AF:
0.0600
AC:
209
AN:
3478
EpiCase
AF:
0.0768
EpiControl
AF:
0.0768

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Developmental and epileptic encephalopathy, 31A (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.20
CADD
Benign
13
DANN
Benign
0.96
PhyloP100
2.6
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2229917;
hg19: chr9-130980937;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.